Nakamura Hiroyuki
Department of Chemistry, Faculty of Science, Gakushuin University, Tokyo, Japan.
Yakugaku Zasshi. 2008 Feb;128(2):193-208. doi: 10.1248/yakushi.128.193.
Boron neutron capture therapy (BNCT) is a binary cancer treatment based on the nuclear reaction of two essentially nontoxic species, (10)B and thermal neutrons. High accumulation and selective delivery of boron into tumor tissue are the most important requirements to achieve efficient neutron capture therapy of cancers. This review focuses on the liposomal boron delivery system (BDS) as a recent promising approach that meets these requirements for BNCT. BDS involves two strategies: (1) encapsulation of boron in the aqueous core of liposomes and (2) accumulation of boron in the liposomal bilayer. Various boronated liposomes have been developed and significant boron accumulation into tumor tissue with high tumor/blood boron ratios has been achieved by BDS.
硼中子俘获疗法(BNCT)是一种基于两种基本无毒物质(硼-10和热中子)的核反应的二元癌症治疗方法。硼在肿瘤组织中的高积累和选择性递送是实现高效癌症中子俘获治疗的最重要要求。本综述重点关注脂质体硼递送系统(BDS),这是一种满足BNCT这些要求的近期有前景的方法。BDS涉及两种策略:(1)将硼包裹在脂质体的水相核心中,以及(2)硼在脂质体双层中的积累。已经开发了各种硼化脂质体,并且通过BDS实现了硼在肿瘤组织中的显著积累以及高肿瘤/血液硼比率。